Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
33 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hartford Hospital
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- Memorial University Medical Center
Savannah, Georgia, United States
- Rush University Medical Center
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Memorial Medical Center
Springfield, Illinois, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Mcfarland Clinic Pc-William R Bliss Cancer Center
Ames, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa-Wide Oncology Research Coalition Ncorp
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Maine Medical Center-Bramhall Campus
Portland, Maine, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Southeast Clinical Oncology Research (scor) Consortium Ncorp
Winston-Salem, North Carolina, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Women and Infants Hospital
Providence, Rhode Island, United States
- Anmed Health Cancer Center
Anderson, South Carolina, United States
- Saint Francis Hospital
Greenville, South Carolina, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- Virginia Commonwealth University/massey Cancer Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jun 2011
- Primary completion
- 16 Jul 2016
- Completion
- 16 Jul 2016
- Last update posted
- 23 Feb 2018
- Registered enrollment
- 35
- Registry id
- NCT01210222
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.